DEXILANT 60mg Capsules (Hard Gelatin)/Modified Release Price, Uses, Alternatives, Dose, and more in UAE 2023
DEXILANT 60mg Capsules (Hard Gelatin)/Modified Release
Drug name DEXILANT 60mg
Active substance Dexlansoprazole
Size : 28 s (7 s Blister x 4)
Type: Capsules (Hard Gelatin)/Modified Release
Company : TAKEDA PHARMACEUTICALS U.S.A., INC.
Uploaded By : Admin
ٍ Visits : 314 visit
Kesslant 60 mg Gastric Lump, Relieves Symptoms of Heartburn - 28 Capsules.
The scientific name
Dexlansoprazole 60 mg capsules
Dexlant 60 mg capsule belongs to:
Acidity and heartburn medications
How does dexlansoprazole work?
The secretion of hydrochloric acid (HCl) into the lumen of the stomach is a process that is mainly regulated by the H(+)/K(+)-ATPase known as the proton pump, large amounts of which are present in the parietal cells of the stomach.
A proton pump inhibitor works by irreversibly blocking the hydrogen/potassium enzyme system, which suppresses the secretion of stomach acid.
Dexlansoprazole is a member of a class called proton pump inhibitors.
Medical uses of Dexlant 60 mg capsule
duodenal ulcer (an ulcer that forms at the beginning of the small intestine).
Treating Helicobacter pylori (the bacteria that can live in your intestines and cause ulcers) to prevent recurring duodenal ulcers.
Benign stomach ulcer (a non-cancerous ulcer that forms in your stomach and overproduces stomach acid).
NSAID-related ulcers (ulcers that form in your gut due to excessive use of NSAIDs and anti-inflammatory drugs).
GERD (acid reflux also known as heartburn): backflow of acid from the stomach into the esophagus (food pipe) that may become inflamed and painful, and this may cause symptoms such as a pain in the chest that radiates to the throat and a sour taste in the mouth.
Erosive esophagitis (acidic irritation that hurts the esophagus): Inflammation that may damage the tissues of your esophagus, the muscular tube that carries food from your mouth to your stomach. Esophagitis can cause pain, difficulty swallowing, and chest pain.
Pathological hypersecretory conditions (problems in the gut leading to excess acid secretion)
How to use Dexlant 60 mg capsule
Take with or without food
Swallow the capsule whole; do not chew
Treatment of erosive esophagitis: 60 mg once daily for up to 8 weeks
Maintenance of healing of erosive esophagitis: 30 mg once daily for up to 6 months
Asymptomatic GERD: 30 mg once daily for 4 weeks
Dosages can be changed in special circumstances, so always follow your doctor s or pharmacist s instructions.
If you take more than you should, speak to a doctor or go to a hospital right away.
If you forget to take a dose, take it as soon as you remember unless it is almost time for your next dose
Do not take a double dose (two doses at the same time) to make up for a forgotten dose.
What are the side effects of Dexlant 60 mg capsule?
Most common side effects reported (2%): diarrhea, abdominal pain, nausea, upper respiratory tract infection, vomiting, and flatulence.
Use of Dexlant 60 mg capsule during pregnancy and lactation
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Welcome to Dwaey, specifically on DEXILANT 60mg Capsules (Hard Gelatin)/Modified Release page.
This medicine contains an important and useful components, as it consists of Dexlansoprazole.
DEXILANT 60mg is available in the market in concentration 60mg/Capsule and in the form of Capsules (Hard Gelatin)/Modified Release.
TAKEDA PHARMACEUTICALS U.S.A., INC. is the producer of DEXILANT 60mg and it is imported from USA.
The most popular alternatives of DEXILANT 60mg are listed downward .
Lets know how to use DEXILANT 60mg Capsules (Hard Gelatin)/Modified Release
Hepatic impairment. Gastric malignancy should be ruled out. Pregnancy and lactation. Lactation: Not known whether distributed into breast milk; discontinue nursing or drug
R-enantiomer of lansoprazole; PPI; binds to H+/K+-exchanging ATPase (proton pump) in gastric parietal cells, resulting in blockage of acid secretion.Dual release formulation.
Increased risk of hypomagnesaemia w/ diuretics and digoxin. May decrease plasma concentration of erlotinib, dasatinib and lapatinib. May decrease the bioavailability of itraconazole and ketoconazole. May increase plasma concentration of cilostazol and methotrexate. Reduced bioavailability w/ antacids and sucralfate. Potentially Fatal: May decrease serum levels and pharmacological effects of rilpivirine and atazanavir.